Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ribavirin aerosol approved for severe cases of RSV in infants and young children.

Literature DB >> 3732682

Ribavirin aerosol approved for severe cases of RSV in infants and young children.

Abstract

Entities: Chemical Species

Mesh：

Substances：

Year: 1986 PMID： 3732682

Source DB: PubMed Journal: FDA Drug Bull ISSN： 0361-4344

Keyword Cloud
Cited

× No keyword cloud information.

9 in total

Review 1. Drug-induced congenital defects: strategies to reduce the incidence.

Authors: M De Santis; B Carducci; A F Cavaliere; L De Santis; G Straface; A Caruso
Journal: Drug Saf Date: 2001 Impact factor: 5.606

2. In vitro and in vivo activities of anti-influenza virus compound T-705.

Authors: Y Furuta; K Takahashi; Y Fukuda; M Kuno; T Kamiyama; K Kozaki; N Nomura; H Egawa; S Minami; Y Watanabe; H Narita; K Shiraki
Journal: Antimicrob Agents Chemother Date: 2002-04 Impact factor: 5.191

3. Management of respiratory viral infections in hematopoietic cell transplant recipients.

Authors: Dimpy P Shah; Shashank S Ghantoji; Victor E Mulanovich; Ella J Ariza-Heredia; Roy F Chemaly
Journal: Am J Blood Res Date: 2012-11-25

4. Antibody Response to the Furin Cleavable Twenty-Seven Amino Acid Peptide (p27) of the Fusion Protein in Respiratory Syncytial Virus (RSV) Infected Adult Hematopoietic Cell Transplant (HCT) Recipients.

Authors: Xunyan Ye; Wanderson Cabral de Rezende; Obinna Patrick Iwuchukwu; Vasanthi Avadhanula; Laura L Ferlic-Stark; Kirtida D Patel; Felipe-Andres Piedra; Dimpy P Shah; Roy F Chemaly; Pedro A Piedra
Journal: Vaccines (Basel) Date: 2020-04-21

Ribavirin aerosol approved for severe cases of RSV in infants and young children.

Review 1. Drug-induced congenital defects: strategies to reduce the incidence.

2. In vitro and in vivo activities of anti-influenza virus compound T-705.

3. Management of respiratory viral infections in hematopoietic cell transplant recipients.

4. Antibody Response to the Furin Cleavable Twenty-Seven Amino Acid Peptide (p27) of the Fusion Protein in Respiratory Syncytial Virus (RSV) Infected Adult Hematopoietic Cell Transplant (HCT) Recipients.

Review 5. Anti-Tumor Potential of IMP Dehydrogenase Inhibitors: A Century-Long Story.

Review 6. Respiratory Viral Infections in Solid Organ and Hematopoietic Stem Cell Transplantation.

Review 7. Review of respiratory syncytial virus infection among older adults and transplant recipients.

Review 8. Respiratory syncytial virus: current and emerging treatment options.

Review 9. Antiviral and antiretroviral use in pregnancy.